Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Shi

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Current Protocols in Stem Cell Biology|January 25, 2020
Xeno-Free Reprogramming of Peripheral Blood Mononuclear Erythroblasts on Laminin-521Christian Skorik, Nathaniel K Mullin, Michael Shi, et al.
DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes|June 12, 2002
Accuracy of genotyping for single nucleotide polymorphisms by a microarray-based single nucleotide polymorphism typing method involving hybridization of short allele-specific oligonucleotidesHironori Iwasaki, Yoichi Ezura, Ryota Ishida, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|April 20, 2026
What Psychiatrists and Psychiatry Residents in Singapore Think About Spirituality in Clinical Care: Results of a SurveyDavid Choon Liang Teo, Michael Shi Yan, Jared Wei Lik Ng, et al.
European Journal of Haematology|November 18, 2014
Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocationChristof Scheid, Donna Reece, Meral Beksac, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2013
Phase I study of dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinomaEric Angevin, Jose A Lopez-Martin, Chia-Chi Lin, et al.
American Journal of Hematology|October 9, 2018
Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysisAbdullah Kutlar, Julie Kanter, Darla K Liles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2014
Phase II results of Dovitinib (TKI258) in patients with metastatic renal cell cancerBernard Escudier, Viktor Grünwald, Alain Ravaud, et al.
Pharmacogenomics|December 19, 2007
Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patientsMizutomo Azuma, Michael Shi, Kathleen D Danenberg, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 2025
Efficacy and safety of surufatinib plus toripalimab in treatment-naive, PD-L1-positive, advanced or metastatic non-small-cell lung cancer and previously treated small-cell lung cancer: an open-label, single-arm, multicenter, multi-cohort phase II trialYing Cheng, Panpan Zhang, Ming Lu, et al.
JTO Clinical and Research Reports|September 30, 2021
Ceritinib Efficacy and Safety in Treatment-Naive Asian Patients With Advanced <i>ALK</i>-Rearranged NSCLC: An ASCEND-4 Subgroup AnalysisDaniel S W Tan, Sarayut Geater, Chong-Jen Yu, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Current Protocols in Stem Cell Biology|January 25, 2020
Xeno-Free Reprogramming of Peripheral Blood Mononuclear Erythroblasts on Laminin-521Christian Skorik, Nathaniel K Mullin, Michael Shi, et al.
DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes|June 12, 2002
Accuracy of genotyping for single nucleotide polymorphisms by a microarray-based single nucleotide polymorphism typing method involving hybridization of short allele-specific oligonucleotidesHironori Iwasaki, Yoichi Ezura, Ryota Ishida, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|April 20, 2026
What Psychiatrists and Psychiatry Residents in Singapore Think About Spirituality in Clinical Care: Results of a SurveyDavid Choon Liang Teo, Michael Shi Yan, Jared Wei Lik Ng, et al.
European Journal of Haematology|November 18, 2014
Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocationChristof Scheid, Donna Reece, Meral Beksac, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2013
Phase I study of dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinomaEric Angevin, Jose A Lopez-Martin, Chia-Chi Lin, et al.
American Journal of Hematology|October 9, 2018
Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysisAbdullah Kutlar, Julie Kanter, Darla K Liles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2014
Phase II results of Dovitinib (TKI258) in patients with metastatic renal cell cancerBernard Escudier, Viktor Grünwald, Alain Ravaud, et al.
Pharmacogenomics|December 19, 2007
Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patientsMizutomo Azuma, Michael Shi, Kathleen D Danenberg, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 2025
Efficacy and safety of surufatinib plus toripalimab in treatment-naive, PD-L1-positive, advanced or metastatic non-small-cell lung cancer and previously treated small-cell lung cancer: an open-label, single-arm, multicenter, multi-cohort phase II trialYing Cheng, Panpan Zhang, Ming Lu, et al.
JTO Clinical and Research Reports|September 30, 2021
Ceritinib Efficacy and Safety in Treatment-Naive Asian Patients With Advanced <i>ALK</i>-Rearranged NSCLC: An ASCEND-4 Subgroup AnalysisDaniel S W Tan, Sarayut Geater, Chong-Jen Yu, et al.
Pageof 4